title: Shrinking lungs syndrome in systemic lupus erythematosus: improvement with inhaled beta-agonist therapy.
abstract: The pathogenesis and therapy of shrinking lungs syndrome in patients with systemic lupus erythematosus remains controversial. It has been previously reported that corticosteroid treatment can be effective. We report a patient with shrinking lungs syndrome who presented a good response to inhaled beta-agonist therapy. Therapeutic approach to this syndrome is discussed.
authors.affiliation: Systemic Autoimmune Diseases Unit, Hospital Clínic i Provincial, Barcelona, Catalonia, Spain.
authors.forename: F J
authors.initials: FJ
authors.lastname: Muñoz-Rodríguez
authors.forename: J
authors.initials: J
authors.lastname: Font
authors.forename: J R
authors.initials: JR
authors.lastname: Badia
authors.forename: C
authors.initials: C
authors.lastname: Miret
authors.forename: J A
authors.initials: JA
authors.lastname: Barberà
authors.forename: R
authors.initials: R
authors.lastname: Cervera
authors.forename: M
authors.initials: M
authors.lastname: Ingelmo
mesh_terms: D000280:Administration, Inhalation; D000318:Adrenergic beta-Agonists / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D000420:Albuterol / Q000008:administration & dosage / Q000627:therapeutic use*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008171:Lung Diseases / Q000188:drug therapy* / Q000209:etiology* / Q000503:physiopathology; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000503:physiopathology; D012123:Pulmonary Ventilation; D013902:Radiography, Thoracic; D014057:Tomography, X-Ray Computed
chemical_list: D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D000420:Albuterol